Management of Insomnia Caused by Keppra
For levetiracetam-induced insomnia, initiate cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, consider dose timing adjustment (moving to morning administration), and if pharmacotherapy is needed, use short-term eszopiclone, zolpidem, or suvorexant while avoiding benzodiazepines due to their cognitive risks. 1
Understanding the Problem
Levetiracetam (Keppra) is documented to cause insomnia in clinical practice, though interestingly, the FDA label lists insomnia as occurring in at least 1% of patients but notes it was "as or more frequent in the placebo group" 2. However, real-world data from veterans with epilepsy found that levetiracetam treatment was actually associated with lower odds of insomnia 3, while objective sleep studies show levetiracetam increases stage 2 sleep and may decrease stage 4 sleep, with patients paradoxically reporting better subjective sleep quality despite some architectural changes 4, 5.
This creates a clinical dilemma: the insomnia may be multifactorial (epilepsy itself, other medications, comorbidities) rather than purely levetiracetam-induced.
Step-by-Step Management Algorithm
1. Verify the Cause
- Assess timing: Did insomnia begin or worsen after starting levetiracetam?
- Review concomitant medications: Lamotrigine is associated with higher odds of insomnia in epilepsy patients 3
- Screen for mood/psychotic disorders, which strongly correlate with insomnia in epilepsy patients 3
- Consider post-traumatic epilepsy etiology, which increases insomnia risk 3
2. Non-Pharmacologic Intervention (First-Line)
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the evidence-based first-line treatment and should be initiated immediately 1. CBT-I includes:
- Sleep restriction therapy
- Stimulus control
- Relaxation training
- Cognitive restructuring of dysfunctional sleep beliefs
- Sleep hygiene education
The American Academy of Sleep Medicine specifically recommends psychological and behavioral interventions over pharmacotherapy for chronic insomnia 1.
3. Medication Adjustment Strategy
Before adding hypnotics, try:
- Dose timing modification: Move levetiracetam to morning administration if currently taking at night
- Dose reduction: If seizure control permits, consider lowering the dose (insomnia may be dose-dependent)
- Medication switch: If insomnia is severe and refractory, discuss switching to an alternative antiepileptic with your neurologist, as levetiracetam may not be the primary culprit based on evidence 3
4. Short-Term Pharmacotherapy (If Needed)
If CBT-I alone is insufficient and insomnia significantly impacts quality of life, add short-term hypnotic therapy:
Preferred agents (based on efficacy for global sleep outcomes) 6:
- Eszopiclone (moderate-strength evidence for short-term improvement)
- Zolpidem (moderate-strength evidence for short-term improvement)
- Suvorexant (dual orexin receptor antagonist - newer option with favorable safety profile)
Important caveats:
- Use for short-term only (guidelines emphasize lack of long-term efficacy data) 6
- In older adults, dose reduction is mandatory due to FDA warnings about cognitive/behavioral changes and driving impairment 6
- Observational data suggest hypnotics may increase risk of dementia, fractures, and major injury, particularly in elderly patients 6
Avoid benzodiazepines due to:
- CNS depression risk
- Tolerance and addiction potential
- Cognitive impairment
- Amnesia risk 7
5. Alternative Pharmacologic Options
Melatonin 2 mg prolonged-release:
- Can facilitate discontinuation of other hypnotics if needed 8
- Does not require special switching protocols 8
- Generally well-tolerated
Daridorexant (newer DORA):
- Can be used without special switching protocols 8
- More favorable safety profile than benzodiazepines
NOT recommended:
- Valerian, chamomile, kava, aromatherapy (not recommended due to risk profile and/or limited benefits) 9
Critical Pitfalls to Avoid
Don't assume levetiracetam is the culprit: Evidence suggests it may actually improve subjective sleep quality 4, 5. Look for other causes first.
Don't use long-term benzodiazepines or Z-drugs: The evidence for long-term efficacy is lacking, and harms accumulate 6, 7.
Don't skip CBT-I: It has the strongest evidence base and should not be bypassed in favor of pills 1.
Don't ignore psychiatric comorbidities: Mood and psychotic disorders are strongly associated with insomnia in epilepsy patients and require concurrent treatment 3.
Don't prescribe hypnotics without a discontinuation plan: If using pharmacotherapy, establish a clear timeline for tapering (typically 10-25% dose reduction weekly for benzodiazepines/Z-drugs) 8.
Monitoring and Follow-Up
- Reassess insomnia severity at 4 weeks using validated tools (Insomnia Severity Index or Pittsburgh Sleep Quality Index)
- If using hypnotics, plan taper after 2-4 weeks
- Continue CBT-I throughout and beyond any pharmacotherapy
- Monitor for cognitive/behavioral changes, particularly in older adults 6